57Moreover, the fact that Ukrain has obtained the status of an orphan medicinal product in the United States and in Australia cannot call into question the Commission’s finding that it offers no significant benefit. Only the European Union provisions laying down criteria for the designation of orphan medicinal products are relevant, so the fact that Ukrain meets the criteria for designation as an orphan medicinal product in other countries is irrelevant in that regard.